Navigation Links
'Texas Monthly' Recognizes Ben DuBose Among the Super Lawyers of Texas
Date:10/2/2009

DALLAS, Oct. 2 /PRNewswire/ -- Ben DuBose, of DuBose Law Firm, PLLC, has been recognized by Law & Politics Media and Texas Monthly as one of the select "Texas Super Lawyers" in the October, 2009 Texas Monthly "Texas Super Lawyers" edition. Earlier this year, Mr. DuBose was chosen as one of the "Best Lawyers in Dallas" by D Magazine. In 2005 he was honored by Law & Politics Media and Texas Monthly magazine as a "Rising Star of Texas Law."

In selecting attorneys for Super Lawyers, Law & Politics Media employs a rigorous, multiphase process. Peer nominations and evaluations are combined with third party research. Each candidate is evaluated on 12 indicators of peer recognition and professional achievement.

During his legal career, Mr. DuBose has practiced law with some of the nation's most prominent law firms representing personal injury victims and consumers. He has obtained significant results for hundreds of mesothelioma victims from coast to coast for over a decade. Mr. DuBose has led the way to discover the asbestos-containing properties of many products previously unknown in asbestos litigation. He was also part of a legal team working with Trial Lawyers for Public Justice seeking to prevent unsafe asbestos abatement practices in the case of Families for Asbestos Compliance, Testing and Safety v. City of St. Louis as well as recent efforts by the EPA and the City of Ft. Worth, Texas to test the controversial "wet method" of asbestos removal.

"My goal as an attorney has always been to help people receive the justice they deserve. I'm honored to have had the opportunity to help injured victims and their families throughout my career," said Mr. DuBose.

Ben DuBose received his J.D., cum laude, from Texas Tech University School of Law. He is admitted to the bar and courts of Texas, Pennsylvania, the U.S. Supreme Court and the United States District Court for the Northern District of Texas. He is a member of the American Bar Association, American Association for Justice, Public Justice, Texas Trial Lawyers Association, Dallas Bar Association, Dallas Bar Foundation, Dallas Trial Lawyers Association and the State Bar College of Texas.

About DuBose Law Firm

The DuBose Law Firm, PLLC was formed to provide personalized legal services ensuring victims are adequately compensated for their losses and defendants are held accountable for their actions. While mesothelioma litigation is the primary practice area of the firm, other severe personal injury and wrongful death cases are also represented. Cases are carefully selected to make certain that each case receives the exacting attention and care that these serious cases require. For more information about the DuBose Law Firm, visit www.DuBoseLawFirm.com or www.DallasMesotheliomaLawyer.com.

SOURCE The DuBose Law Firm, PLLC


'/>"/>
SOURCE The DuBose Law Firm, PLLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Texas Supreme Court Rules Against Medicare HMOs in Hospital Reimbursement Fight
2. Texas Largest Physician Carrier Announces 5th Successive Rate Cut on Anniversary of Lawsuit Reform
3. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
4. South Texas Doctors Report More Severe Cases of Community Staph Super Bug Hospitalizing Children
5. Texas Aviation Services: Over 20 Years of Creating Flying Emergency Rooms for Airborne EMS Customers in US and Latin America
6. Dermatologists identify North Texas leishmaniasis outbreak
7. Precedent Launches Revolutionary Individual Health Insurance Plans in Texas
8. Health Care Service Corporation Provides Personal Clinical Summaries to Members of its Blue Cross and Blue Shield plans in Illinois, New Mexico, Oklahoma and Texas
9. Sesame Street Exhibition Makes Texas Premier at The Health Museum
10. The Law Offices of John David Hart: Texas Man Sues Medtronic in Body-Snatching Case
11. Viant Acquires Texas True Choice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... and London UK (PRWEB) , ... June 27, 2017 , ... ... to a clinical study is whether they can trust the sponsor to pay them ... is vital that sponsors and CROs establish payment strategies that encourage sites to work ...
(Date:6/27/2017)... ... June 27, 2017 , ... From June 20-22, ... event was held in Syracuse, New York, where EarQ is headquartered. , Together, ... how to connect with today’s savvy consumer, and the latest in hearing technology. ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... of Atmosera Managed Azure Services . The trusted, transparent, and secure solution ... the company’s growing customer base. Atmosera’s next generation services include integrated capabilities for ...
(Date:6/27/2017)... CA (PRWEB) , ... June 27, 2017 , ... ... orthodontic treatments . Orthodontics is a dental specialty that focuses on treating alignment ... Benefits include improved aesthetics and function. , North Hollywood dentist , ...
(Date:6/26/2017)... ... June 26, 2017 , ... ... & Sexual Medicine Specialists, in collaboration with the Fertility Center of California, is ... care: PESA (percutaneous epidydimal sperm aspiration) and TESA (percutaneous testicular sperm extraction). These ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)...  Exactly 50 years ago today, the Monterey Pop Festival ... as the San Francisco "Summer of Love."  To celebrate the ... innovations in strategic market research portals that it will begin ... of Northern Light,s "Summer of Love (For Our Customers)."  ... ...
(Date:6/14/2017)...  In 2016, Embodied Labs took top ... and came away with $25,000 in seed-fund investment. Embodied ... as "entering the life of another" and by the ... to medical professionals in an entirely new dimension." Building ... finalist for the Department of Education,s EdSimChallenge, where they ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company (NYSE: ... three Phase 3 studies of galcanezumab, an investigational treatment ... late-breaking data on several key secondary endpoints for galcanezumab ... from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be ... scientific meeting in Boston . ...
Breaking Medicine Technology: